Torno Capital, LLC Reneo Pharmaceuticals, Inc. Transaction History
Torno Capital, LLC
- $2.13 Trillion
- Q2 2024
A detailed history of Torno Capital, LLC transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Torno Capital, LLC holds 1,000 shares of RPHM stock, worth $1,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$1,430% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RPHM
# of Institutions
67Shares Held
29.3MCall Options Held
51.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD4.79MShares$6.84 Million0.68% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$4.28 Million0.55% of portfolio
-
Highbridge Capital Management LLC New York, NY2.92MShares$4.17 Million0.94% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$3.86 Million0.49% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.67MShares$3.82 Million2.88% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $35M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...